220 related articles for article (PubMed ID: 8438569)
21. Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study.
Hoshikawa N; Kojima A; Yasuda A; Takayashiki E; Masuko S; Chiba J; Sata T; Kurata T
J Gen Virol; 1991 Oct; 72 ( Pt 10)():2509-17. PubMed ID: 1919528
[TBL] [Abstract][Full Text] [Related]
22. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
[TBL] [Abstract][Full Text] [Related]
23. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.
Quillent C; Borman AM; Paulous S; Dauguet C; Clavel F
Virology; 1996 May; 219(1):29-36. PubMed ID: 8623542
[TBL] [Abstract][Full Text] [Related]
24. Proteolytic cleavage at the Gag-Pol junction in avian leukosis virus: differences in vitro and in vivo.
Stewart L; Vogt VM
Virology; 1994 Oct; 204(1):45-59. PubMed ID: 7522375
[TBL] [Abstract][Full Text] [Related]
25. Effect of HIV constructs containing protease-reverse transcriptase fusion proteins on viral replication.
Cherry E; Morin N; Wainberg MA
AIDS; 1998 Jun; 12(9):967-75. PubMed ID: 9662192
[TBL] [Abstract][Full Text] [Related]
26. A domain directly C-terminal to the major homology region of human immunodeficiency type 1 capsid protein plays a crucial role in directing both virus assembly and incorporation of Gag-Pol.
Chien AI; Liao WH; Yang DM; Wang CT
Virology; 2006 Apr; 348(1):84-95. PubMed ID: 16442581
[TBL] [Abstract][Full Text] [Related]
27. p6gag of human and simian immunodeficiency viruses is tolerant to small in-frame deletions downstream of the late domain.
Pikora CA; Wittish C; Desrosiers RC
Virology; 2006 Mar; 346(2):479-89. PubMed ID: 16332383
[TBL] [Abstract][Full Text] [Related]
28. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
Wu X; Liu H; Xiao H; Kappes JC
Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
[TBL] [Abstract][Full Text] [Related]
29. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease.
Ross EK; Fuerst TR; Orenstein JM; O'Neill T; Martin MA; Venkatesan S
AIDS Res Hum Retroviruses; 1991 May; 7(5):475-83. PubMed ID: 1873082
[TBL] [Abstract][Full Text] [Related]
30. Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen.
Larrouy L; Charpentier C; Landman R; Capitant C; Chazallon C; Yeni P; Peytavin G; Damond F; Brun-Vezinet F; Descamps D;
AIDS; 2011 Nov; 25(17):2143-8. PubMed ID: 21904187
[TBL] [Abstract][Full Text] [Related]
31. Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness?
de Oliveira T; Engelbrecht S; Janse van Rensburg E; Gordon M; Bishop K; zur Megede J; Barnett SW; Cassol S
J Virol; 2003 Sep; 77(17):9422-30. PubMed ID: 12915557
[TBL] [Abstract][Full Text] [Related]
32. Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1.
Hill MK; Hooker CW; Harrich D; Crowe SM; Mak J
J Virol; 2001 Aug; 75(15):6835-40. PubMed ID: 11435562
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
Meek TD; Lambert DM; Dreyer GB; Carr TJ; Tomaszek TA; Moore ML; Strickler JE; Debouck C; Hyland LJ; Matthews TJ
Nature; 1990 Jan; 343(6253):90-2. PubMed ID: 1688646
[TBL] [Abstract][Full Text] [Related]
34. HIV-2 viral protein X association with the GAG p27 capsid protein.
Horton R; Spearman P; Ratner L
Virology; 1994 Mar; 199(2):453-7. PubMed ID: 8122374
[TBL] [Abstract][Full Text] [Related]
35. Effect of two novel inhibitors of the human immunodeficiency virus protease on the maturation of the HIV gag and gag-pol polyproteins.
Overton HA; McMillan DJ; Gridley SJ; Brenner J; Redshaw S; Mills JS
Virology; 1990 Nov; 179(1):508-11. PubMed ID: 2219737
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 gag proteins in virions and in infected cell fractions.
Sharova NK; Grigor'ev VB; Bukrinskaya AG
Biomed Sci; 1991; 2(3):279-84. PubMed ID: 1751761
[TBL] [Abstract][Full Text] [Related]
37. Morphogenesis of recombinant HIV-2 gag core particles.
Voss G; Kirchhoff F; Nick S; Moosmayer D; Gelderblom H; Hunsmann G
Virus Res; 1992 Jul; 24(2):197-210. PubMed ID: 1529643
[TBL] [Abstract][Full Text] [Related]
38. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.
Wagner R; Fliessbach H; Wanner G; Motz M; Niedrig M; Deby G; von Brunn A; Wolf H
Arch Virol; 1992; 127(1-4):117-37. PubMed ID: 1456888
[TBL] [Abstract][Full Text] [Related]
39. Recombinant HIV1 protease secreted by Saccharomyces cerevisiae correctly processes myristylated gag polyprotein.
Pichuantes S; Babé LM; Barr PJ; Craik CS
Proteins; 1989; 6(3):324-37. PubMed ID: 2695931
[TBL] [Abstract][Full Text] [Related]
40. Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein.
Tritch RJ; Cheng YE; Yin FH; Erickson-Viitanen S
J Virol; 1991 Feb; 65(2):922-30. PubMed ID: 1987379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
